US Federal 2025-2026 Regular Session All Bills (Page 250)

Page 250 of 667
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1875

Introduced
 
Introduced
5/22/25  
Streamlining Federal Cybersecurity Regulations Act of 2025This bill establishes an interagency committee to review and align cybersecurity regulations and requirements imposed by executive agencies.The committee, to be led and administered by the Office of the National Cyber Director, must include the heads of each executive agency with statutory authority to enforce mandatory cybersecurity requirements. Agencies must generally consult with the committee before promulgating or amending cybersecurity requirements.The committee must develop a regulatory framework for the harmonization of agencies’ cybersecurity requirements. Under the bill, harmonization means the alignment of cybersecurity requirements to consist of a common set of minimum requirements that are applicable across sectors and sector-specific requirements as necessary. Specifically, the framework must contain processes for (1) establishing a reciprocal compliance mechanism for minimum requirements applicable to entities regulated by more than one agency; and (2) identifying and developing recommendations to address cybersecurity requirements that are overly burdensome, inconsistent, or contradictory. In developing this framework, the committee must seek public comment and consult with industry experts and stakeholders.Once the framework is developed and published, the committee must select agencies to carry out a pilot program to apply the framework to a sampling of their cybersecurity requirements.In consultation with the committee, the Office of Management and Budget must issue guidance to federal agencies on coordinating with the committee and, after the pilot program is complete, on ensuring cybersecurity requirements are consistent with the framework and lessons learned from the pilot program.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1824

Introduced
 
Introduced
5/21/25  
A bill to improve defense cooperation between the United States and Taiwan, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1825

Introduced
 
Introduced
5/21/25  
A bill to amend the Research Facilities Act to address deferred maintenance at agricultural research facilities, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1826

Introduced
 
Introduced
5/21/25  
Growing Rural Agricultural Infrastructure Needs to Deliver Rising Yields Act or the GRAIN DRY ActThis bill specifies that funds provided under the Farm Storage Facility Loan Program may be used to construct or upgrade storage facilities for propane that is primarily used for agricultural production.This Department of Agriculture loan program provides low-interest financing for agricultural producers to build or upgrade commodity storage facilities. Some agricultural producers use propane to power agricultural operations (e.g., grain dryers, irrigation engines, and barn heating).
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1827

Introduced
 
Introduced
5/21/25  
A bill to authorize the expedited removal of aliens who are criminal gang members, members of foreign terrorist organizations, or have been convicted of certain specified crimes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1871

Introduced
 
Introduced
5/22/25  
A bill to require the Secretary of Homeland Security to develop a plan to identify, integrate, and deploy new, innovative, disruptive, or other emerging or advanced technologies that are safe and secure to enhance U.S. Customs and Border Protection's capabilities to meet its mission needs along international borders and at ports of entry.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1872

Introduced
 
Introduced
5/22/25  
Refer
5/22/25  
Report Pass
6/25/25  
Engrossed
11/10/25  
A bill to direct the Secretary of Commerce to conduct a study on the feasibility of manufacturing in the United States products for critical infrastructure sectors, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1870

Introduced
 
Introduced
5/22/25  
A bill to adjust the boundary of the Santa Monica Mountains National Recreation Area to include the Rim of the Valley Corridor, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1867

Introduced
 
Introduced
5/22/25  
Closing the De Minimis Loophole ActThis bill immediately terminates de minimis treatment for goods originating in China and phases out such treatment for goods originating from all other countries. (Current law allows for U.S. imports under a de minimis threshold of $800 per shipment to enter free of tariffs, fees, and taxes.)Specifically, de minimis treatment ends (1) with respect to goods from China, beginning on the bill's enactment date (with an exception for goods already loaded onto a vessel or in transit during the three-day period that ends on the enactment date); and (2) with respect to goods from any other country, 120 days after the bill's enactment.During the 120-day period beginning on the date of the bill's enactment, the Department of the Treasury must carry out a rulemaking process. Among other elements, the rulemaking process must ensure that data requirements and entry procedures for informal modes of entry are sufficient to ensure the effective enforcement of U.S. laws and the efficient and accurate collection of duties, fees, and taxes.The bill directs Treasury, in the case of shipments sent through the international postal network, to determine appropriate fees and procedures to ensure consistency between the treatment of shipments by the U.S. Postal Service and other shipments.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1868

Introduced
 
Introduced
5/22/25  
Refer
5/22/25  
A bill to amend title 38, United States Code, to expand access by veterans to critical access hospitals and affiliated clinics under the Veterans Community Care Program, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1869

Introduced
 
Introduced
5/22/25  
A bill to require the Secretary of Defense to carry out an operational experimentation program to evaluate the military utility of optionally piloted vehicle rotary-wing aircraft, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1864

Introduced
 
Introduced
5/22/25  
A bill to amend the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 to modify the provision relating to public reporting of Chinese military companies, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1865

Introduced
 
Introduced
5/22/25  
A bill to amend the Internal Revenue Code of 1986 to repeal the excise tax on indoor tanning services.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1866

Introduced
 
Introduced
5/22/25  
A bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2026 through 2030, and for other purposes.
US

US Federal 2025-2026 Regular Session

US Federal Senate Bill SB1862

Introduced
 
Introduced
5/22/25  
Optimizing Research Progress Hope And New Cures Act or the ORPHAN Cures ActThis bill modifies certain provisions under the Medicare Drug Price Negotiation Program with respect to orphan drugs.The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. The program does not apply to orphan drugs that are approved to treat only one rare disease or condition.The bill modifies these provisions so as to exclude any period in which a drug was an orphan drug from market approval calculations. It also excludes orphan drugs that are approved to treat more than one rare disease or condition from the program.